
Endocrinologist, Thyroidologist. Asst prof of Internal Medicine @SapienzaRoma. #thyroid disease, thyroid #nodule and #cancer. @GiGrani@med-mastodon.com
Roma, Lazio
Joined March 2012
- Tweets1.1K
- Following1.2K
- Followers1.5K
- Likes2.2K
Pinned Tweet
Can we improve the prediction of treatment response in differentiated #thyroidCancer? A prospective multicenter study used a #DataDriven model to refine the prediction of persistent/recurrent disease, outperforming the current risk stratification system. doi.org/10.1210/clinem/dgad0…
Our recent original study explores the impact of #lenvatinib treatment on #lipid alterations in patients with advanced thyroid cancer. Findings suggest significant changes in cholesterol & triglycerides during therapy.
link.springer.com/article/10… 📊 #ThyroidCancer #OpenAccess
1
6
227
Giorgio Grani, MD, PhD retweeted
Although a cancer diagnosis of any kind can be scary, papillary and follicular thyroid cancer have a good prognosis, with a very high long-term survival rate (over 90%). @AmThyroidAssn @ThyCaInc @TheEndo @TheAACE #CheckYourNeck #ThyCa #ThyroidCancer #THYCAM2024
Giorgio Grani, MD, PhD retweeted
In 2015 new ATA guidelines offered thyroid lobectomy as a choice for treatment in patients with low risk thyroid cancers. How often do these folks need re-operation? @BeninatoToni and her team @RWJMS answer this question in a new article @ThyroidJournal.
ow.ly/3oQe50T8Gno
Giorgio Grani, MD, PhD retweeted
🎉🙌Free access to special issues of @EndoPath until 15th October @DrJuhlin @DianaEstherossi @TheEndoSociety @HeadNeckPathol @Pathologists @
Giorgio Grani, MD, PhD retweeted
Source: academic.oup.com/jcem/articl…
Giorgio Grani, MD, PhD retweeted
A prospective multicenter study with a data-driven model has improved prediction of treatment response in differentiated thyroid cancer (DTC), outperforming the ATA risk stratification system.
🏥💻 Our new paper explores the use of ontology-based data preparation for enhancing #diabetes treatment #Analytics.
doi.org/10.1007/s42979-024-0…
1
93
Leveraging 13 years of #realworld EMR data, collected by the AMD Annals Project, this approach is set to optimize #healthcare research using routinely collected data.
doi.org/10.1007/s42979-024-0…
116
Giorgio Grani, MD, PhD retweeted
Dive deep into thyroid care with Dr. Mike Tuttle in this Int'l Thyroid Tumor Board webinar! 📚💡 Essential insights for medical professionals. Watch the recording here >> youtube.com/watch?utm_campai… #ThyroidCare #MedicalEducation
Giorgio Grani, MD, PhD retweeted
Can the intersection between #TSH and genetics lead to more individualized #thyroid references ranges? New data in @ThyroidJournal reviewed by Dr. @JohnsonThomasMD in CT now.
ow.ly/u7Ck50T3sap
#medtwitter #endotwitter #hypothyroidism #ThyroidFunction #thyroid #SNPs
Giorgio Grani, MD, PhD retweeted
Our newest paper published @AmJSurgery:
Our analysis demonstrated that pre-op Tg is significantly associated with ATA structural risk of recurrence and response to therapy and may have the potential to guide initial therapy and follow-up management.
pubmed.ncbi.nlm.nih.gov/3900…
Giorgio Grani, MD, PhD retweeted
The review tree 🌲
Here are the different types of reviews you should know: ⬇️
Giorgio Grani, MD, PhD retweeted
Next TIROxMDS Journal Club on Sept 6th! - mailchi.mp/be4a775996a3/tiro…
Giorgio Grani, MD, PhD retweeted
People with PCOS have a higher risk of type 2 diabetes, hypertension, hepatocellular carcinoma, and depression or anxiety compared with controls. They also have a higher risk for cardiovascular disease, hepatic steatosis, and hepatic fibro-inflammation.
academic.oup.com/jcem/advanc…
Giorgio Grani, MD, PhD retweeted
On our latest podcast episode, Drs. Pasieka & Robenshtok discuss active surveillance and its benefits for patients. Tune in for expert insights and practical tips. Don't miss this episode 👉 voices-of-wisdom.podbean.com… #ThyroidCancer #Spotify #ApplePodcast
Giorgio Grani, MD, PhD retweeted
Long-Term Look at Selpercatinib in RET-Activated Thyroid Cancer ascopost.com/news/august-202… #thycsm #thyroidcancer #oncology
New data-driven thresholds for #thyroglobulin levels in #thyroid #cancer follow-up! Data suggests lower cutoffs for optimal management. Findings support reliability of 1-year Tg levels in clinical decision-making. doi.org/10.1210/clinem/dgae5… #thyroidcancer #patientmanagement
#DataDriven Tg thresholds were established based on the 97th percentile of Tg levels in disease-free individuals: 1.97 ng/mL for pts undergoing #thyroidectomy alone and 0.84 ng/mL for pts receiving #radioiodine treatment #OpenAccess #JCEM @EndoSocJournals doi.org/10.1210/clinem/dgae5…




























